Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    INTUNIV

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,726Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    29/11/2025 PharmaBlock Sciences
    China
    		 PharmaBlock Pharmaceuticals (Zhejiang) Co. , Ltd. 307MF10107 Guanfacine hydrochloride 2025-08-21 2025-08-21 No. 11, Weiqi Road, Hangzhou Bay Shangyu Economic and Technological Development Area, Shaoxing City, Zhejiang Province, China
    29/11/2025 Quimica Sintetica
    Spain
    		 Quimica Syntetica S. A. 227MF10293 Guanfacine hydrochloride 2015-12-24 2017-01-31 Calle Dulcinea, s/n 28805 Alcala De Henares Madrid Spain